-+ 0.00%
-+ 0.00%
-+ 0.00%

Akebia Therapeutics Q2 Sales $62.472M Beat $47.637M Estimate

Benzinga·08/07/2025 11:03:41
Listen to the news
Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $62.472 million which beat the analyst consensus estimate of $47.637 million by 31.14 percent. This is a 43.13 percent increase over sales of $43.648 million the same period last year.